Tender notice from Bulgaria, published on 12 Dec 2019.
Executive Summary
The ????????????? ???????? ??????? ?? ??????? ??????? „?-? ?????? ????????“ ?? has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Bulgaria. This Tender notice was published on 12 Dec 2019 and is scheduled to close on 08 Jan 2020, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 38870889, while the tender notice number is 588461-2019 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Body governed by public law Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union Award criteria: Lowest price CPV code: 33600000, 33661000, 33600000, 33661000, 33610000, 33620000, 33692000, 33622000, 33630000, 33642000, 33621100, 33632000, 33670000, 33662100, 33693100, 33696000, 33696800, 33692300, 33652000 CPV Description: Pharmaceutical products. Medicinal products for the nervous system. Medicinal products for the alimentary tract and metabolism. Medicinal products for the blood, blood-forming organs and the cardiovascular system. Medical solutions. Medicinal products for the cardiovascular system. Medicinal products for dermatology and the musculo-skeletal system. Systemic hormonal preparations, excl. sex hormones. Antithrombotic agents. Medicinal products for the musculo-skeletal system. Medicinal products for the respiratory system. Ophthalmologicals. Toxins. Reagents and contrast media. X-ray contrast media. Enteral feeds. Antineoplastic and immunomodulating agents. "Delivery of medicinal products necessary for the activity of MOBAL" Dr. Stefan Cherkesov "AD - Veliko Tarnovo for a period of 12 months" Torate of medicinal products needed for the activity of Mobil "Dr. Stefan Cherkesov" AD - Veliko Tarnovo for a period of 12 months. The specification of the medicinal products is divided into 646 nomenclature units, divided into 15 (fifteen) separate groups. the following groups are included in the subject of the contract: No 1 Medicinal products for the treatment of the nervous system, No 2alimentary tract, No. 3 Medicinal products for the treatment of the circulatory system, No. 4 Plasma substitutes and infusion solutions, No. 5 Medicinal products for the treatment of the cardiovascular system, No. 6 Dermatologicals, No. 7 Hormonal preparations, No. 8 Antiinfectives for systemic use, No 9 Antineoplastic medicinal products, No 10products for the treatment of the musculoskeletal system, No. 11 Respiratory system medicinal products, No. 12 Ophthalmic preparations, No. 13 Antidotes, No. 14 Diagnostic medicinal products, No. 15. Food. Main Site: Hospital pharmacy at MOBAL "Dr. Cherkesov "AD, Veliko Tarnovo, 1 Nish Str. Includes 1 to 78, namely: 1 N01AB06 Isofluranum fl 100ml bottle 10 2 N01AB06 Isofluranum fl 250 ml bottle10 3 N01AB08 Sevofluran with free of charge delivery of closed evaporators. Filling system without adapter fl.250 ml vial 500 4 N01AF03 Thiopentalum Natrium fl.1g vial 1000 5 N01AH01 Fentanyli citras 0.05 (mg / ml), 2 ml vial 1500 6 N01AH01 Fentanyli citras amp. 0.05 mg / ml 5 ml. ampoule 3000 7 N01AH06 Remifentanilum amp.5mg / 10ml ampoule 1400 8 N01AX03 Ketaminum fl. 500 mg. 10 ml. 300 9 bottle N01AX07Etomidat amp. 2 mg/ml 10 ml ампула 80 10 N01AX10 Propofolum 10 mg/ml - 20 ml. ампула 3600 11 N01AX10 Propofolum 10 mg/ml - 50 ml. флакон 300 12 N01AX10 Propofolum lipid emulsion amp. 10 mg/ml 20 ml ампула 1500 13 N01BB01 Bupivacaini hydrochloridum 5 mg/ml - 4 ml ампула 200 14 N01BB01 Bupivacaini hydrochloridum heavy 5 mg/ml - 4 ml ампула 1000 15 N01BB02 Lidocainum amp. 20 mg/ml 2 ml. ампула 3000 16 N01BB02 Lidocainum amp. 20 mg/ml 10 ml. ампула 5500 17 N01BB02 Lidocainum spray 10 % 38 g. флакон 30 18 N01BB09 Ropivacaine amp.5 mg/ml 10ml ампула 600 19 N01BB09 Ropivacaine amp. 7.5mg/ml 10 ml ампула 100 20 N01BB52 Zidocain hydrochlorid; Chlochexidin hydrochlorid gel 12, 5 брой 3500 21 N02AA01 Morphini hydrochloridum amp. 10 mg/ml 1 ml. ампула 200 22 N02AA01 Morphini hydrochloridum amp. 20 mg/ml 1 ml. ampoule 700 23 N02AA05 Oxycodone hydrochloride tabl. 10 mg. tablet 3500 24 N02AA05 Oxycodone hydrochloride tabl. 20 mg. tablet 1000 25 N02AA55 Oxycodone / Naloxon tabl. 10 mg./5mg Tablet 2000 26 N02AA55 Oxycodone / Naloxon Tabl. 20 mg./10mg tablet 500 27 N02AB02 Pethidini hydrochloridum amp.50 mg / 2ml 2 ml ampoule 3000 28 N02AX02 Tramadoli hydrochloridum amp.50 mg / ml 2ml ampoule 2300 29 N02AX02 Tramadoli hydrochloridum / Paracetamol tabl. 37.5mg / 325mg Tablet 1000 30 N02BA01 Acidum acetylsalicylicum tabl. 500 mg. tablet 2000 31 N02BA01 Acidum acetylsalicylicum tabl. 100 mg. tablet 6000 32 N02BB02 Metamizolum amp.500 mg / ml 2 ml. ampoule 50000 33 N02BB02 Metamizolum tabl. 500 mg. tablet 2000 34 N02BB02 Metamizolum sol.500mg / ml 20ml vial 100 35 N02BE01 Paracetamolum syr. 120 mg./5 ml vial 400 36 N02BE01 Paracetamolum supp.150 mg. number 200 37 N02BE01 Paracetamolum tabl. 500 mg. tablet 5000 38 N02BE01 Paracetamolum 10 mg / ml 100ml vial 5500 39 N02BE01 Paracetamolum 10 mg / ml 50ml vial 1000 40 N02BE01 Paracetamolum 10 mg / ml 10ml ampoule 100 41 N03AA02 Phenobarbitalum natrium amp. 200mg - 2 ml ampoule 500 42 N03AB02 Phenytoinum tabl. 100 mg. tablet 1000 43 N03AE01Clonazepamum tabl. 0.5 mg tablet 600 44 N03AF01 Carbamazepinum tabl. 200 mg. tablet 5000 45 N03AF02 Oxcarbazepin tabl.300 mg tablet 1000 46 N03AG01 Acidum valproicum amp.500mg / 5ml ampoule 1000 47 N03AG01 Acidum valproicum chrono tabl.300 mg. tablet 2000 48 N03AG01 Acidum valproicum chrono cheese. vial 20 49 N03AG01 Sodium valproas amp. 400 mg. soh ampoule 2500 50 N03AX12 Gabapentin caps. 300mg tablet 2000 51 N04BA02 Co beneldopa tabl. 250 mg. tablet 500 52 N04BA02 Co beneldopa tabl. disp 125 mg. tablet 500 53 N04BB01 Amantadine tabl. 100 mg. tablet 500 54 N04BB01 Amantadine fl. 200mg./ 500 ml bottle 700 55 N05AA01 Chlorpromazines hydrochloridum amp.5mg / ml 5 ml. ampoule 1000 56 N05AA01 Chlorpromazini hydrochloridum amp10mg / ml 5 ml. ampoule 1000 57 N05AD01 Haloperidoli decanoas amp. 5 mg./ml - 1 ml. ампула 700 58 N05BA01 Diazepamum 5 mg/ml - 2 ml ампула 3000 59 N05BA01 Diazepamum tabl. 10 mg. таблетка 1000 60 N05BA01 Diazepamum tabl. 5 mg. таблетка 1000 61 N05CD08 Midazolami maleas amp. 5 mg. 5 ml. ампула 3000 62 N05CD08 Midazolami maleas amp. 15 mg. 3 ml. ампула 4500 63 N05CM11 Natrium bromatum amp. 100 mg/ml 5 ml. ампула 3000 64 N06BX03 Pyracetamum fl. 12mg./ 60 ml флакон1000 65 N06BX03 Pyracetam amp. 3 g / 15 ml ampoule 18000 66 N06BX03 Pyracetamum tabl. 800 mg. tablet 3000 ..... up to 78 units, detailed in documentation 1. Participants must be registered as traders under Bulgarian or European Union law or a State party to the Agreement on the European Economic Areaand to have the right to wholesale medicinal products in accordance with the provisions of the Law on Medicinal Products. Participants shall hold a valid Manufacturing License issued under the LPPM (in the cases under Art. 196, Para 1 of the LPPM) or a Wholesale and / or Import Authorization for Medicinal Products issued by the BDA or the regulatory authority of another a Member State in accordance with Chapter NineWholesale trade in medicinal products from LMPHM. Compliance with this condition is evidenced by filling in the relevant column of the model of OEDOP / part IV, Letter A item 1 of OEDOP / and with indication of the body that issued the document, scope, date of issuing, validity and indication of the national databases containing the declared circumstances or the competent authorities which by lawThe government of the country in which the participant is established is obliged to provide information. the lawful conduct of the procedure. * At the stage of contracting, the tenderer selected as the contractor should submit forcertified by the participant a copy of: - Authorization for wholesale of medicinal products; or - Certificate of registration for wholesale trade in the territory of the Republic of Bulgaria of the persons holding a permit for this activity, issued by a regulatory body of the respective Member State; or - Import Authorization; or - Production permit, issued in accordance with the procedure of the Law on Animal Health. 2.The participant must have alid license issued in accordance with the LCNSP, when the participant participates for the supply of medicinal products containing narcotic substances from the lists under Art. 3 para. 2, items 2 and 3 of the LCNSP. Compliance with this condition is evidenced by filling in the relevant column of the model of OEDOP / part IV, Letter A item 1 of OEDOP / and by indicating the body that issued the document, scope, date of issue, period of validity andan indication of the national databases containing the declared circumstances or the competent authorities which, under the law of the country in which the participant is established, are obliged to provide information. item 2, by which the information specified in the EDES is proved, when necessary * At the stage of contracting, the participant selected as a contractor shall submit a certified copy of a valid license issued by the participant, issued in accordance with Article 32 of the LCNSP. 47, para. 10 of the PDPA The Contracting Authority permits the submission of one application / one EDPS for all lots. The Contracting Authority has no economic and financial requirementson the status of the participants. A participant in the procurement procedure may be any Bulgarian or foreign natural or legal person or their associations, as well as any other entity entitled to perform deliveries under the legislation of the country in which it is established. that meet the requirements set out in the Public Procurement Act (PPA)Each of the participants is represented by the manager or by a specially authorized person with a notarized power of attorney. 54, para. 1 of the PPL. Other grounds for removal from participation on the grounds of Article 107 of the Public Procurement Act and a participant for whomit is subject to circumstances under Article 3, point 8 of the Law on Economic and Financial Relations with the companies, registered in jurisdictions with preferential tax regime, related persons and their real owners. submission of a tender, the tenderer declares no grounds for removal from the procedure and compliance with the selection criteria by submitting a tender.Documents through which the information specified in the EDES can be proved may be requested under the terms of Article 67, paragraph 5 of the Public Procurement Act. for the contract, the tenderer designated as a contractor shall submit up-to-date documents certifying the absence of grounds for removal, as well as compliance with the selection criteria.subcontractors and third parties, if any. Participant for whom the grounds under Art. 54, para. 1 of the PPA has the right to present evidence that it has taken measures that guarantee its reliability, despite the existence of a proper reason for removal.java.As evidence of the participant's reliability, documents under Article 58 of the Public Procurement Act shall be presented. AD, branch of Veliko Tarnovo. Performance guarantee under Art. 111, para. 2 of the PPA is set at 5 / five /% of the value of the public procurement contract.provide in one of the following forms:. monetary amount; 2. bank guarantee; 3. Documents related to participation in the procedure are presented by the participant, or by his authorized representative - personally or through a postal or other courier service with registered mail with registered receipt, to the address referred to byThe documents must be submitted in a sealed opaque package.The tender submitted must have a minimum validity of 180 / hundred and eighty / days from the date of expiry of the deadline for submission of proposals. must be not less than 60% of the shelf life declared by the manufacturer. Internet address (URL): http://mobaltarnovo.nit.bg
The bid deadline for Contract notice: Pharmaceutical products was 08 Jan 2020. Bidding is closed.
This tender has been issued by ????????????? ???????? ??????? ?? ??????? ??????? „?-? ?????? ????????“ ?? in Bulgaria.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products, 33661000 - Medicinal products for the nervous system, 33610000 - Medicinal products for the alimentary tract and metabolism, 33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system, 33692000 - Medical solutions, 33622000 - Medicinal products for the cardiovascular system, 33630000 - Medicinal products for dermatology and the musculo-skeletal system, 33642000 - Systemic hormonal preparations, excl. sex hormones, 33621100 - Antithrombotic agents, 33632000 - Medicinal products for the musculo-skeletal system, 33670000 - Medicinal products for the respiratory system, 33662100 - Ophthalmologicals, 33693100 - Toxins, 33696000 - Reagents and contrast media, 33696800 - X-ray contrast media, 33692300 - Enteral feeds, 33652000 - Antineoplastic and immunomodulating agents.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 38870889. The purchaser document reference is 588461-2019.